Antithrombotic and Antiplatelet Therapy in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention

Nov 28, 2016 by in CARDIOLOGY Comments Off on Antithrombotic and Antiplatelet Therapy in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention

We read the meta-analysis by Fabrizio D′ Ascenzo et al that compared the various antithrombotic and antiplatelet regimens in patients receiving oral anticoagulants (OACs) who underwent percutaneous coronary intervention (PCI). We…

read more

Are Changes in Serum Potassium Levels During Admissions for Acute Decompensated Heart Failure Irrelevant for Prognosis: The End of the Story?

Nov 28, 2016 by in CARDIOLOGY Comments Off on Are Changes in Serum Potassium Levels During Admissions for Acute Decompensated Heart Failure Irrelevant for Prognosis: The End of the Story?

We read the article of Khan et al, “Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction,” published in the American Journal of…

read more

Reply: Are Changes in Serum Potassium Levels During Admissions for Acute Decompensated Heart Failure Irrelevant for Prognosis: The End of the Story?

Nov 28, 2016 by in CARDIOLOGY Comments Off on Reply: Are Changes in Serum Potassium Levels During Admissions for Acute Decompensated Heart Failure Irrelevant for Prognosis: The End of the Story?

We thank Kok et al for their careful review of our report. There is no question that extreme hypokalemia and hyperkalemia are potentially life threatening. However, despite our hypothesis that changes…

read more

Meta-Analysis of Comparison of the Newer Oral P2Y 12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non–ST-Elevation Acute Coronary Syndrome

Nov 28, 2016 by in CARDIOLOGY Comments Off on Meta-Analysis of Comparison of the Newer Oral P2Y 12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non–ST-Elevation Acute Coronary Syndrome

Newer oral P2Y 12 inhibitors are more potent and have faster onset of action than clopidogrel. However, the efficacy and safety in patients with non–ST-elevation acute coronary syndrome (NSTE-ACS) are…

read more

Impact of Hospital Volume on Outcomes of Lower Extremity Endovascular Interventions (Insights from the Nationwide Inpatient Sample [2006 to 2011])

Nov 28, 2016 by in CARDIOLOGY Comments Off on Impact of Hospital Volume on Outcomes of Lower Extremity Endovascular Interventions (Insights from the Nationwide Inpatient Sample [2006 to 2011])

Our primary objective was to study postprocedural outcomes and hospitalization costs after peripheral endovascular interventions and the multivariate predictors affecting the outcomes with emphasis on hospital volume. The study cohort…

read more
Get Clinical Tree app for offline access